You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameMagnesium Sulfate
Accession NumberDB00653  (APRD01080)
TypeSmall Molecule
GroupsApproved, Vet Approved
DescriptionA small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Structure
Thumb
Synonyms
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulphate
Magnesium(ii) sulfate
Magnesiumsulfat
MgSO4
External Identifiers Not Available
Approved Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousGENERAL INJECTABLES AND VACCINES, INC.2015-09-16Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousFresenius Kabi USA, LLC2000-08-08Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousCardinal Health2000-08-08Not applicableUs
Magnesium Sulfateinjection, solution4 g/100mLintravenousHospira, Inc.1994-06-24Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousFresenius Kabi USA, LLC2016-01-29Not applicableUs
Magnesium Sulfateinjection, solution4 g/50mLintravenousHospira, Inc.1994-06-24Not applicableUs
Magnesium Sulfate Dressingliquid45 %topicalDumex Medical Canada Inc.Not applicableNot applicableCanada
Magnesium Sulfate In Dextroseinjection, solution10 mg/mLintravenousHospira, Inc.1995-07-11Not applicableUs
Magnesium Sulfate In Dextroseinjection, solution20 mg/mLintravenousHospira, Inc.1995-07-11Not applicableUs
Magnesium Sulfate Inj 20% USPliquid200 mgintramuscular; intravenousSandoz Canada Incorporated1978-12-31Not applicableCanada
Magnesium Sulfate Inj 50%liquid500 mgintramuscularKripps Pharmacy Ltd.1980-12-31Not applicableCanada
Magnesium Sulfate Inj 50%liquid500 mgintramuscular; intravenousLyphomed, Division Of Fujisawa Canada Inc.1992-12-311996-09-10Canada
Magnesium Sulfate Inj 500mg/mlsolution500 mgintramuscular; intravenousAbbott Laboratories, Limited1981-12-311999-04-01Canada
Magnesium Sulfate Injectionsolution500 mgintramuscular; intravenousFresenius Kabi Canada Ltd1992-12-31Not applicableCanada
Magnesium Sulfate Injection 50% USPliquid500 mgintramuscular; intravenousSandoz Canada Incorporated1984-12-31Not applicableCanada
Approved Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Magnesium Sulfateinjection, solution40 mg/mLintravenousFresenius Kabi USA, LLC2016-03-15Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousHospira, Inc.1987-07-22Not applicableUs
Magnesium Sulfateinjection1 g/100mLintravenousWG Critical Care, LLC2016-03-08Not applicableUs
Magnesium Sulfateinjection, solution80 mg/mLintravenousFresenius Kabi USA, LLC2016-03-15Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousX Gen Pharmaceuticals, Inc.2014-02-23Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousHospira, Inc.2000-04-25Not applicableUs
Magnesium Sulfateinjection, solution5 g/10mLintramuscular; intravenousGeneral Injectables & Vaccines, Inc2010-08-01Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousPhysicians Total Care, Inc.2006-12-12Not applicableUs
Magnesium Sulfate In 5% Dextroseinjection, solution1 g/100mLintravenousFresenius Kabi USA, LLC2016-03-07Not applicableUs
Approved Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Epsom Saltgranule, for solution1 g/goral; topicalYour Military Exchange2002-12-18Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalFoodhold U.S.A., Llc2015-05-06Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalKroger Co.1993-10-21Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalValu Merchandisers, Co.2014-10-15Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalWalgreens2015-07-13Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalSUPERVALU INC.2005-03-21Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalPublix Super Markets, Inc2014-09-05Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalWinCo Foods, LLC2015-05-21Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalTOPCO ASSOCIATES, LLC1999-07-15Not applicableUs
Epsom Saltgranule100 kg/100kgoralWestern Family1998-06-05Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalMeijer Distribution, Inc2015-07-21Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalWakefern Food Corp2014-05-01Not applicableUs
Epsom Saltgranule1 g/goralPublix Super Markets, Inc.,2013-07-03Not applicableUs
Epsom Saltgranule, for solution100 g/100goral; topicalGood Neighbor Pharmacy2010-01-01Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalShop Ko Stores Operating Co., Llc2009-06-05Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalDZA Brands, LLC2008-02-27Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalVi Jon1998-07-15Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalGeiss, Destin and Dunn, Inc1992-07-15Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalMeijer Distribution, Inc2013-04-26Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalDiscount Drug Mart2002-12-02Not applicableUs
Epsom Saltcrystal1.81 kg/100kgoral; topicalCardinal Health2012-03-26Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalSAFEWAY INC2002-11-12Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalDolgencorp, LLC1993-10-21Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalTarget Corporation1996-12-12Not applicableUs
Epsom Saltgranule1.81 kg/100kgoral; topicalKinray, Inc.2012-06-14Not applicableUs
Epsom Saltgranule, for solution1 g/goral; topicalFoodhold U.S.A., Llc2015-05-06Not applicableUs
Epsom Salt Magnesium Sulfategranule1 g/goral; topicalCVS Pharmacy2014-12-31Not applicableUs
Epsom Salt Pws 100%powder for solution100 %oralJedmon Products Ltd.1990-12-312006-03-22Canada
Epsom Salt Soaking Solutiongranule2.72 kg/2.72kgtopicalAdvanced Beauty Systems, Inc.2012-06-13Not applicableUs
Epsom Saltspowder100 %oralR.W. Packaging Ltd.1987-12-312004-07-21Canada
Epsom SaltspowderoralStanley Pharmaceuticals, A Division Of Vita Health Products Inc.1972-12-312000-07-27Canada
Epsom Saltspowder100 %oralLawton's Drug Stores Ltd.1987-12-311997-04-02Canada
Epsom SaltspowderoralDawson Traders Ltd.1977-12-312006-03-22Canada
Epsom Salts Naturalcrystal100 g/100goral; topicalFirst Aid Research Corp.2015-05-15Not applicableUs
Epsom Salts Reliefgranule100 g/100goralBlue Cross Laboratories, Inc.2010-07-09Not applicableUs
Eucalyptus Scented Natural Epsom Saltpowder10 g/10gtopicalAnhui Twowin Machinery Imp. & Exp. Co., Ltd.2016-01-26Not applicableUs
Eucalyptus Scented Natural Epsom Saltpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-26Not applicableUs
Green Tea Chamomile Natural Epsom Saltpowder10 g/10gtopicalAnhui Twowin Machinery Imp. & Exp. Co., Ltd.2016-01-26Not applicableUs
Green Tea Chamomile Natural Epsom Saltpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-26Not applicableUs
Health Smart Natural Epsom Saltgranule, for solution1 g/goralInternational Wholesale, Inc.2013-08-01Not applicableUs
Health Smart Natural Epsom Saltgranule, for solution1 g/goralInternational Wholesale, Inc.2013-08-01Not applicableUs
Humco Epson Saltpowder, for solution1000 mg/goralHumco Holding Group, Inc.1998-03-25Not applicableUs
Morton Natural Epsom Saltgranule, for solution1 kg/kgoral; topicalMorton Salt, Inc.2012-09-01Not applicableUs
Natural Epsom Saltpowder10 g/10gtopicalAnhui Twowin Machinery Imp. & Exp. Co., Ltd.2014-10-09Not applicableUs
Natural Epsom Saltpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-26Not applicableUs
Natural Epsom Saltpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-27Not applicableUs
Natural Epsom Saltpowder10 g/10gtopicalMy Import USA Inc2014-10-09Not applicableUs
Natural Epsom Salt Lavenderpowder10 g/10gtopicalAnhui Twowin Machinery Imp. & Exp. Co., Ltd.2016-01-26Not applicableUs
Natural Epsom Salt Lavenderpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-26Not applicableUs
Royal Epsom Saltgranule, for solution1 kg/kgoralFilo America2014-10-29Not applicableUs
Sel D EpsompowderoralProduits Marc O (1987) Inc., Division Of Technilab Inc.1989-12-152000-08-24Canada
Spearmint and Menthol Scented Natural Epsom Saltpowder10 g/10gtopicalPoint Guard Marketing Inc.2016-01-27Not applicableUs
Spearmint and Menthol Scented Natural Epsom Saltpowder10 g/10gtopicalAnhui Twowin Machinery Imp. & Exp. Co., Ltd.2016-01-27Not applicableUs
Unapproved/Other Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousCardinal Health2000-08-08Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousAmerican Regent, Inc.1990-09-30Not applicableUs
Magnesium Sulfateinjection, solution20 g/250mLintravenousCantrell Drug Company2011-07-25Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousAmerican Regent, Inc.1990-09-30Not applicableUs
Magnesium Sulfateinjection500 mg/mLintramuscular; intravenousGeneral Injectables & Vaccines, Inc2010-09-01Not applicableUs
Magnesium Sulfateinjection, solution500 mg/mLintramuscular; intravenousAmerican Regent, Inc.1990-09-30Not applicableUs
Magnesium Sulfateinjection, solution.5 g/mLintramuscular; intravenousGeneral Injectables & Vaccines, Inc2010-08-01Not applicableUs
Magnesium Sulfateinjection, solution20 g/500mLintravenousCantrell Drug Company2011-02-21Not applicableUs
International BrandsNot Available
Brand mixtures
NameLabellerIngredients
Concept DHAUs Pharmaceutical Corporation
Concept ObUs Pharmaceutical Corporation
Eau Purgative RigaGlendale Agencies
Magnesium CapAlsi Cie Ltee
Magnesium Sulfate In 5% Dextrose Inj(20mg/ml)Hospira Healthcare Corporation
Multiple Electrolyte Additive InjInternational Medication Systems Ltd.
Solution CardaLaboratoire Atlas Inc
Suprep Bowel PrepBraintree Laboratories, Inc.
Tandem ObUs Pharmaceutical Corporation
Tandem PlusUs Pharmaceutical Corporation
Vamin NFresenius Kabi Ab
Salts
Name/CASStructureProperties
Magnesium sulfate heptahydrate
ThumbNot applicableDBSALT001240
Categories
UNIIML30MJ2U7I
CAS number7487-88-9
WeightAverage: 120.368
Monoisotopic: 119.936771076
Chemical FormulaMgO4S
InChI KeyInChIKey=CSNNHWWHGAXBCP-UHFFFAOYSA-L
InChI
InChI=1S/Mg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2
IUPAC Name
magnesium(2+) ion sulfate
SMILES
[Mg++].[O-]S([O-])(=O)=O
Taxonomy
DescriptionThis compound belongs to the class of inorganic compounds known as alkaline earth metal sulfates. These are inorganic compounds in which the largest oxoanion is sulfate, and in which the heaviest atom not in an oxoanion is an alkaline earth metal.
KingdomInorganic compounds
Super ClassMixed metal/non-metal compounds
ClassAlkaline earth metal oxoanionic compounds
Sub ClassAlkaline earth metal sulfates
Direct ParentAlkaline earth metal sulfates
Alternative Parents
Substituents
  • Alkaline earth metal sulfate
  • Inorganic oxide
  • Inorganic salt
  • Acyclic compound
Molecular FrameworkAcyclic compounds
External Descriptors
Pharmacology
IndicationUsed for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
PharmacodynamicsMagnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.
Mechanism of actionMagnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca2+ influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.
Related Articles
AbsorptionNot Available
Volume of distributionNot Available
Protein binding25-30%
Metabolism

None

Route of eliminationMagnesium is excreted solely by the kidney at a rate proportional to the serum concentration and glomerular filtration.
Half life43.2 hours (for newborns)
ClearanceNot Available
ToxicityLD50 = 1200 mg/kg (rat, subcutaneous). May be harmful if swallowed. May act as an irritant. Adverse reactions include hypotension, ECG changes, diarrhea, urinary retention, CNS depression and respiratory depression.
Affected organisms
  • Humans and other mammals
PathwaysNot Available
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.7487
Blood Brain Barrier+0.9646
Caco-2 permeable-0.6267
P-glycoprotein substrateNon-substrate0.9137
P-glycoprotein inhibitor INon-inhibitor0.9194
P-glycoprotein inhibitor IINon-inhibitor0.9904
Renal organic cation transporterNon-inhibitor0.9521
CYP450 2C9 substrateNon-substrate0.8775
CYP450 2D6 substrateNon-substrate0.8213
CYP450 3A4 substrateNon-substrate0.7007
CYP450 1A2 substrateNon-inhibitor0.7767
CYP450 2C9 inhibitorNon-inhibitor0.7602
CYP450 2D6 inhibitorNon-inhibitor0.9115
CYP450 2C19 inhibitorNon-inhibitor0.7547
CYP450 3A4 inhibitorNon-inhibitor0.9759
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9577
Ames testNon AMES toxic0.5773
CarcinogenicityCarcinogens 0.8111
BiodegradationReady biodegradable0.943
Rat acute toxicity2.4160 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.7988
hERG inhibition (predictor II)Non-inhibitor0.9446
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Pharmacoeconomics
Manufacturers
  • Abraxis pharmaceutical products
  • Hospira inc
Packagers
Dosage forms
FormRouteStrength
Capsule, liquid filledoral
Capsuleoral
Liquidoral
Crystaloral; topical1.81 kg/100kg
Granuleoral1 g/g
Granuleoral100 kg/100kg
Granuleoral; topical1.81 kg/100kg
Granule, for solutionoral; topical1 g/g
Granule, for solutionoral; topical100 g/100g
Granuleoral; topical1 g/g
Powder for solutionoral100 %
Granuletopical2.72 kg/2.72kg
Powderoral
Powderoral100 %
Crystaloral; topical100 g/100g
Granuleoral100 g/100g
Granule, for solutionoral1 g/g
Powder, for solutionoral1000 mg/g
Injectionintramuscular; intravenous500 mg/mL
Injectionintravenous1 g/100mL
Injection, solutionintramuscular; intravenous.5 g/mL
Injection, solutionintramuscular; intravenous5 g/10mL
Injection, solutionintramuscular; intravenous500 mg/mL
Injection, solutionintravenous20 g/250mL
Injection, solutionintravenous20 g/500mL
Injection, solutionintravenous4 g/50mL
Injection, solutionintravenous4 g/100mL
Injection, solutionintravenous40 mg/mL
Injection, solutionintravenous80 mg/mL
Liquidtopical45 %
Injection, solutionintravenous1 g/100mL
Solutionintravenous
Injection, solutionintravenous10 mg/mL
Injection, solutionintravenous20 mg/mL
Liquidintramuscular; intravenous200 mg
Liquidintramuscular500 mg
Solutionintramuscular; intravenous500 mg
Liquidintramuscular; intravenous500 mg
Granule, for solutionoral; topical1 kg/kg
Liquidintravenous
Powdertopical10 g/10g
Granule, for solutionoral1 kg/kg
Solution, concentrateoral
Prices
Unit descriptionCostUnit
Elliotts b solution ampule4.71USD ml
Magnesium Sulfate 50% Solution 2ml Vial0.92USD vial
Magnesium sulfate powder0.29USD g
Magnesium-ns 6 g/50 ml bag0.29USD ml
Magnesium-ns 4 g/50 ml bag0.27USD ml
Magnesium-ns 3 g/50 ml bag0.26USD ml
Magnesium sulfate-ns 2 gm bag0.25USD ml
Magnesium sulfate-ns 1 gm bag0.24USD ml
Magnesium-d5w 1 gm/100 ml soln0.07USD ml
Magnesium-lr 20 g/500 ml0.03USD ml
Magnesium-lr 40 g/500 ml bag0.03USD ml
Magnesium-lr 50 g/500 ml bag0.02USD ml
Epsom salt 100% powder0.01USD g
Magnesium sulf 4% iv soln0.01USD ml
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US6946149 No2003-03-072023-03-07Us
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point1124 °C (decomposition)Not Available
water solubility710 mg/mLNot Available
logP-0.91Not Available
Predicted Properties
PropertyValueSource
logP-0.84ChemAxon
pKa (Strongest Acidic)-3ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area80.26 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity11.53 m3·mol-1ChemAxon
Polarizability5.81 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Mass Spec (NIST)Not Available
SpectraNot Available
References
Synthesis Reference

Shinichi Yamamoto, Akifumi Sekitani, “BASIC MAGNESIUM SULFATE GRANULE, AND PROCESS FOR PRODUCTION THEREOF.” U.S. Patent US20110042297, issued February 24, 2011.

US20110042297
General References
  1. Blitz M, Blitz S, Hughes R, Diner B, Beasley R, Knopp J, Rowe BH: Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest. 2005 Jul;128(1):337-44. [PubMed:16002955 ]
  2. Yokoyama K, Takahashi N, Yada Y, Koike Y, Kawamata R, Uehara R, Kono Y, Honma Y, Momoi MY: Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev. 2010 Mar;86(3):187-91. doi: 10.1016/j.earlhumdev.2010.02.007. Epub 2010 Mar 12. [PubMed:20226604 ]
  3. Wedig KE, Kogan J, Schorry EK, Whitsett JA: Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol. 2006 Jun;26(6):371-4. [PubMed:16724078 ]
  4. Nassar AH, Sakhel K, Maarouf H, Naassan GR, Usta IM: Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scand. 2006;85(9):1099-103. [PubMed:16929415 ]
  5. Malaeb SN, Rassi AI, Haddad MC, Seoud MA, Yunis KA: Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol. 2004 May;34(5):384-6. Epub 2004 Feb 18. [PubMed:14985884 ]
  6. Matsuda Y, Maeda Y, Ito M, Sakamoto H, Masaoka N, Takada M, Sato K: Effect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest. 1997;44(2):82-8. [PubMed:9286718 ]
  7. Schanler RJ, Smith LG Jr, Burns PA: Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest. 1997;43(4):236-41. [PubMed:9194621 ]
  8. Santi MD, Henry GW, Douglas GL: Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop. 1994 Mar-Apr;14(2):249-53. [PubMed:8188843 ]
  9. Holcomb WL Jr, Shackelford GD, Petrie RH: Magnesium tocolysis and neonatal bone abnormalities: a controlled study. Obstet Gynecol. 1991 Oct;78(4):611-4. [PubMed:1923163 ]
  10. Cumming WA, Thomas VJ: Hypermagnesemia: a cause of abnormal metaphyses in the neonate. AJR Am J Roentgenol. 1989 May;152(5):1071-2. [PubMed:2705341 ]
  11. Lamm CI, Norton KI, Murphy RJ, Wilkins IA, Rabinowitz JG: Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr. 1988 Dec;113(6):1078-82. [PubMed:3193315 ]
  12. McGuinness GA, Weinstein MM, Cruikshank DP, Pitkin RM: Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses. Obstet Gynecol. 1980 Nov;56(5):595-600. [PubMed:7432730 ]
  13. Riaz M, Porat R, Brodsky NL, Hurt H: The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol. 1998 Nov-Dec;18(6 Pt 1):449-54. [PubMed:9848759 ]
External Links
ATC CodesB05XA05D11AX05A12CC02V04CC02A06AD04
AHFS Codes
  • 28:12.92
  • 40:12.00
  • 56:12.00
  • 84:92.00
  • 92:02.00*
PDB EntriesNot Available
FDA labelNot Available
MSDSDownload (72.1 KB)
Interactions
Drug Interactions
Drug
2-HYDROXY-1,4-NAPHTHOQUINONEThe risk or severity of adverse effects can be increased when 2-HYDROXY-1,4-NAPHTHOQUINONE is combined with Magnesium Sulfate.
2-mercaptobenzothiazoleThe risk or severity of adverse effects can be increased when 2-mercaptobenzothiazole is combined with Magnesium Sulfate.
7-NitroindazoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of 7-Nitroindazole.
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Magnesium Sulfate.
AcepromazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Magnesium Sulfate.
AceprometazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine.
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Magnesium Sulfate.
adipiplonMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of adipiplon.
adipiplonThe risk or severity of adverse effects can be increased when adipiplon is combined with Magnesium Sulfate.
AgomelatineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Agomelatine.
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Magnesium Sulfate.
Alendronic acidThe serum concentration of Alendronic acid can be decreased when it is combined with Magnesium Sulfate.
AlfacalcidolThe serum concentration of Magnesium Sulfate can be increased when it is combined with Alfacalcidol.
AlfaxaloneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Alfaxalone.
AlfaxaloneThe risk or severity of adverse effects can be increased when Alfaxalone is combined with Magnesium Sulfate.
AlfentanilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Alfentanil.
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Magnesium Sulfate.
AlfuzosinAlfuzosin may increase the hypotensive activities of Magnesium Sulfate.
AlphacetylmethadolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Alphacetylmethadol.
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Magnesium Sulfate.
AlprazolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Magnesium Sulfate.
AmisulprideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Amisulpride.
AmisulprideThe risk or severity of adverse effects can be increased when Amisulpride is combined with Magnesium Sulfate.
AmitriptylineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
AmitriptylineThe risk or severity of adverse effects can be increased when Amitriptyline is combined with Magnesium Sulfate.
AmlodipineThe risk or severity of adverse effects can be increased when Amlodipine is combined with Magnesium Sulfate.
AmobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.
AmobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Amobarbital.
AmorolfineThe risk or severity of adverse effects can be increased when Amorolfine is combined with Magnesium Sulfate.
AmoxapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
AmoxapineThe risk or severity of adverse effects can be increased when Amoxapine is combined with Magnesium Sulfate.
AmperozideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Amperozide.
AmperozideThe risk or severity of adverse effects can be increased when Amperozide is combined with Magnesium Sulfate.
Amphotericin BThe risk or severity of adverse effects can be increased when Amphotericin B is combined with Magnesium Sulfate.
AmrinoneThe risk or severity of adverse effects can be increased when Amrinone is combined with Magnesium Sulfate.
AN2690The risk or severity of adverse effects can be increased when AN2690 is combined with Magnesium Sulfate.
AnidulafunginThe risk or severity of adverse effects can be increased when Anidulafungin is combined with Magnesium Sulfate.
AripiprazoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Magnesium Sulfate.
ArtemetherThe risk or severity of adverse effects can be increased when Artemether is combined with Magnesium Sulfate.
ArticaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Articaine.
ArticaineThe risk or severity of adverse effects can be increased when Articaine is combined with Magnesium Sulfate.
AsenapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Asenapine.
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Magnesium Sulfate.
AtosibanThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Atosiban.
Atracurium besylateMagnesium Sulfate may increase the neuromuscular blocking activities of Atracurium besylate.
AzaperoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Azaperone.
AzaperoneThe risk or severity of adverse effects can be increased when Azaperone is combined with Magnesium Sulfate.
AzelastineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
AzelastineThe risk or severity of adverse effects can be increased when Azelastine is combined with Magnesium Sulfate.
AzelnidipineThe risk or severity of adverse effects can be increased when Azelnidipine is combined with Magnesium Sulfate.
AzimilideThe risk or severity of adverse effects can be increased when Azimilide is combined with Magnesium Sulfate.
BaclofenMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Baclofen.
BaclofenThe risk or severity of adverse effects can be increased when Baclofen is combined with Magnesium Sulfate.
Bafilomycin A1The risk or severity of adverse effects can be increased when Bafilomycin A1 is combined with Magnesium Sulfate.
BarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Barbital.
BarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Barbital.
BarnidipineThe risk or severity of adverse effects can be increased when Barnidipine is combined with Magnesium Sulfate.
BenidipineThe risk or severity of adverse effects can be increased when Benidipine is combined with Magnesium Sulfate.
BenzocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.
BenzocaineThe risk or severity of adverse effects can be increased when Benzocaine is combined with Magnesium Sulfate.
Benzoic AcidThe risk or severity of adverse effects can be increased when Benzoic Acid is combined with Magnesium Sulfate.
Benzyl alcoholMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.
Benzyl alcoholThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Magnesium Sulfate.
BepridilThe risk or severity of adverse effects can be increased when Bepridil is combined with Magnesium Sulfate.
BifonazoleThe risk or severity of adverse effects can be increased when Bifonazole is combined with Magnesium Sulfate.
BrexpiprazoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.
BrexpiprazoleThe risk or severity of adverse effects can be increased when Brexpiprazole is combined with Magnesium Sulfate.
BrimonidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.
BromazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Magnesium Sulfate.
BrompheniramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.
BrompheniramineThe risk or severity of adverse effects can be increased when Brompheniramine is combined with Magnesium Sulfate.
BrotizolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.
BrotizolamThe risk or severity of adverse effects can be increased when Brotizolam is combined with Magnesium Sulfate.
BupivacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.
BupivacaineThe risk or severity of adverse effects can be increased when Bupivacaine is combined with Magnesium Sulfate.
BuprenorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
BuprenorphineThe risk or severity of adverse effects can be increased when Buprenorphine is combined with Magnesium Sulfate.
BuspironeMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Buspirone.
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Magnesium Sulfate.
ButabarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Magnesium Sulfate.
ButacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butacaine.
ButacaineThe risk or severity of adverse effects can be increased when Butacaine is combined with Magnesium Sulfate.
ButalbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
ButalbitalThe risk or severity of adverse effects can be increased when Butalbital is combined with Magnesium Sulfate.
ButambenMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butamben.
ButambenThe risk or severity of adverse effects can be increased when Butamben is combined with Magnesium Sulfate.
ButenafineThe risk or severity of adverse effects can be increased when Butenafine is combined with Magnesium Sulfate.
ButethalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butethal.
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Magnesium Sulfate.
ButoconazoleThe risk or severity of adverse effects can be increased when Butoconazole is combined with Magnesium Sulfate.
ButorphanolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Magnesium Sulfate.
CalcitriolThe serum concentration of Magnesium Sulfate can be increased when it is combined with Calcitriol.
CandicidinThe risk or severity of adverse effects can be increased when Candicidin is combined with Magnesium Sulfate.
CarbamazepineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Magnesium Sulfate.
CarbinoxamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Carbinoxamine.
CarbinoxamineThe risk or severity of adverse effects can be increased when Carbinoxamine is combined with Magnesium Sulfate.
CarfentanilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Carfentanil.
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Magnesium Sulfate.
CarisoprodolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Carisoprodol.
CarisoprodolThe risk or severity of adverse effects can be increased when Carisoprodol is combined with Magnesium Sulfate.
CarvedilolCarvedilol may increase the hypotensive activities of Magnesium Sulfate.
CaspofunginThe risk or severity of adverse effects can be increased when Caspofungin is combined with Magnesium Sulfate.
CeruleninThe risk or severity of adverse effects can be increased when Cerulenin is combined with Magnesium Sulfate.
CetirizineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.
CetirizineThe risk or severity of adverse effects can be increased when Cetirizine is combined with Magnesium Sulfate.
Chloral hydrateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.
Chloral hydrateThe risk or severity of adverse effects can be increased when Chloral hydrate is combined with Magnesium Sulfate.
ChlordiazepoxideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Magnesium Sulfate.
ChlormezanoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.
ChlormezanoneThe risk or severity of adverse effects can be increased when Chlormezanone is combined with Magnesium Sulfate.
ChloroprocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.
ChloroprocaineThe risk or severity of adverse effects can be increased when Chloroprocaine is combined with Magnesium Sulfate.
ChloroxineThe risk or severity of adverse effects can be increased when Chloroxine is combined with Magnesium Sulfate.
ChlorphenamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
ChlorphenamineThe risk or severity of adverse effects can be increased when Chlorphenamine is combined with Magnesium Sulfate.
ChlorpromazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Magnesium Sulfate.
ChlorprothixeneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Magnesium Sulfate.
ChlorzoxazoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Magnesium Sulfate.
CiclopiroxThe risk or severity of adverse effects can be increased when Ciclopirox is combined with Magnesium Sulfate.
CilnidipineThe risk or severity of adverse effects can be increased when Cilnidipine is combined with Magnesium Sulfate.
CimetidineThe serum concentration of Magnesium Sulfate can be increased when it is combined with Cimetidine.
CinchocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
CinchocaineThe risk or severity of adverse effects can be increased when Cinchocaine is combined with Magnesium Sulfate.
CinnarizineThe risk or severity of adverse effects can be increased when Cinnarizine is combined with Magnesium Sulfate.
CitalopramThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Citalopram.
ClemastineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clemastine.
ClemastineThe risk or severity of adverse effects can be increased when Clemastine is combined with Magnesium Sulfate.
ClevidipineThe risk or severity of adverse effects can be increased when Clevidipine is combined with Magnesium Sulfate.
ClidiniumMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clidinium.
ClidiniumThe risk or severity of adverse effects can be increased when Clidinium is combined with Magnesium Sulfate.
ClobazamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clobazam.
ClobazamThe risk or severity of adverse effects can be increased when Clobazam is combined with Magnesium Sulfate.
ClodronateThe serum concentration of Clodronate can be decreased when it is combined with Magnesium Sulfate.
clomethiazoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of clomethiazole.
clomethiazoleThe risk or severity of adverse effects can be increased when clomethiazole is combined with Magnesium Sulfate.
ClomipramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
ClomipramineThe risk or severity of adverse effects can be increased when Clomipramine is combined with Magnesium Sulfate.
ClonazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.
ClonazepamThe risk or severity of adverse effects can be increased when Clonazepam is combined with Magnesium Sulfate.
ClonidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clonidine.
ClonidineThe risk or severity of adverse effects can be increased when Clonidine is combined with Magnesium Sulfate.
ClopidogrelThe therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium Sulfate.
ClorazepateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clorazepate.
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Magnesium Sulfate.
ClotrimazoleThe risk or severity of adverse effects can be increased when Clotrimazole is combined with Magnesium Sulfate.
ClozapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Clozapine.
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Magnesium Sulfate.
CocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cocaine.
CocaineThe risk or severity of adverse effects can be increased when Cocaine is combined with Magnesium Sulfate.
CodeineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Codeine.
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Magnesium Sulfate.
CyclizineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.
CyclizineThe risk or severity of adverse effects can be increased when Cyclizine is combined with Magnesium Sulfate.
CyclobenzaprineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cyclobenzaprine.
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Magnesium Sulfate.
CyclosporineThe risk or severity of adverse effects can be increased when Cyclosporine is combined with Magnesium Sulfate.
CyproheptadineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
CyproheptadineThe risk or severity of adverse effects can be increased when Cyproheptadine is combined with Magnesium Sulfate.
DantroleneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.
DantroleneThe risk or severity of adverse effects can be increased when Dantrolene is combined with Magnesium Sulfate.
DapiprazoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dapiprazole.
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Magnesium Sulfate.
DapoxetineDapoxetine may increase the orthostatic hypotensive activities of Magnesium Sulfate.
DapoxetineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Dapoxetine.
DarodipineThe risk or severity of adverse effects can be increased when Darodipine is combined with Magnesium Sulfate.
Decanoic AcidThe risk or severity of adverse effects can be increased when Decanoic Acid is combined with Magnesium Sulfate.
DeferiproneThe serum concentration of Deferiprone can be decreased when it is combined with Magnesium Sulfate.
deramciclaneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of deramciclane.
deramciclaneThe risk or severity of adverse effects can be increased when deramciclane is combined with Magnesium Sulfate.
DesfluraneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Desflurane.
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Magnesium Sulfate.
DesipramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
DesipramineThe risk or severity of adverse effects can be increased when Desipramine is combined with Magnesium Sulfate.
DesloratadineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
DesloratadineThe risk or severity of adverse effects can be increased when Desloratadine is combined with Magnesium Sulfate.
DetomidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Detomidine.
DetomidineThe risk or severity of adverse effects can be increased when Detomidine is combined with Magnesium Sulfate.
DexbrompheniramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.
DexbrompheniramineThe risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Magnesium Sulfate.
DexmedetomidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dexmedetomidine.
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Magnesium Sulfate.
DextromoramideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dextromoramide.
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Magnesium Sulfate.
DextropropoxypheneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dextropropoxyphene.
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Magnesium Sulfate.
DezocineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dezocine.
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Magnesium Sulfate.
DiazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Diazepam.
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Magnesium Sulfate.
DifenoxinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.
DifenoxinThe risk or severity of adverse effects can be increased when Difenoxin is combined with Magnesium Sulfate.
DihydrocodeineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Magnesium Sulfate.
DihydroetorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dihydroetorphine.
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Magnesium Sulfate.
DihydromorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dihydromorphine.
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Magnesium Sulfate.
DiltiazemThe risk or severity of adverse effects can be increased when Diltiazem is combined with Magnesium Sulfate.
DimenhydrinateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
DimenhydrinateThe risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Magnesium Sulfate.
DiphenhydramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Magnesium Sulfate.
DiphenoxylateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Diphenoxylate.
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Magnesium Sulfate.
DolutegravirThe serum concentration of Dolutegravir can be decreased when it is combined with Magnesium Sulfate.
DoramectinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Doramectin.
DoramectinThe risk or severity of adverse effects can be increased when Doramectin is combined with Magnesium Sulfate.
DotarizineThe risk or severity of adverse effects can be increased when Dotarizine is combined with Magnesium Sulfate.
DoxazosinDoxazosin may increase the hypotensive activities of Magnesium Sulfate.
DoxepinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
DoxepinThe risk or severity of adverse effects can be increased when Doxepin is combined with Magnesium Sulfate.
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Magnesium Sulfate.
DPDPEMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of DPDPE.
DPDPEThe risk or severity of adverse effects can be increased when DPDPE is combined with Magnesium Sulfate.
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Magnesium Sulfate.
DroperidolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Droperidol.
DroperidolThe risk or severity of adverse effects can be increased when Droperidol is combined with Magnesium Sulfate.
DrotebanolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Magnesium Sulfate.
DyclonineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Dyclonine.
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Magnesium Sulfate.
EcgonineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ecgonine.
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Magnesium Sulfate.
ECGONINE METHYL ESTERMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of ECGONINE METHYL ESTER.
ECGONINE METHYL ESTERThe risk or severity of adverse effects can be increased when ECGONINE METHYL ESTER is combined with Magnesium Sulfate.
EconazoleThe risk or severity of adverse effects can be increased when Econazole is combined with Magnesium Sulfate.
EfavirenzMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Efavirenz.
EfavirenzThe serum concentration of Magnesium Sulfate can be decreased when it is combined with Efavirenz.
EfinaconazoleThe risk or severity of adverse effects can be increased when Efinaconazole is combined with Magnesium Sulfate.
EfonidipineThe risk or severity of adverse effects can be increased when Efonidipine is combined with Magnesium Sulfate.
EltrombopagThe serum concentration of Eltrombopag can be decreased when it is combined with Magnesium Sulfate.
EnfluraneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Enflurane.
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Magnesium Sulfate.
EntacaponeMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Entacapone.
EntacaponeThe risk or severity of adverse effects can be increased when Entacapone is combined with Magnesium Sulfate.
EperisoneThe risk or severity of adverse effects can be increased when Eperisone is combined with Magnesium Sulfate.
EscitalopramThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Escitalopram.
EstazolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Estazolam.
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Magnesium Sulfate.
EszopicloneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Magnesium Sulfate.
EthanolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
EthanolThe risk or severity of adverse effects can be increased when Ethanol is combined with Magnesium Sulfate.
EthchlorvynolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Magnesium Sulfate.
EthosuximideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethosuximide.
EthosuximideThe risk or severity of adverse effects can be increased when Ethosuximide is combined with Magnesium Sulfate.
EthotoinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
EthotoinThe risk or severity of adverse effects can be increased when Ethotoin is combined with Magnesium Sulfate.
Ethyl carbamateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethyl carbamate.
Ethyl carbamateThe risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Magnesium Sulfate.
Ethyl loflazepateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Magnesium Sulfate.
EthylmorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Magnesium Sulfate.
EtidocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Etidocaine.
EtidocaineThe risk or severity of adverse effects can be increased when Etidocaine is combined with Magnesium Sulfate.
Etidronic acidThe serum concentration of Etidronic acid can be decreased when it is combined with Magnesium Sulfate.
EtifoxineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.
EtifoxineThe risk or severity of adverse effects can be increased when Etifoxine is combined with Magnesium Sulfate.
EtizolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Etizolam.
EtizolamThe risk or severity of adverse effects can be increased when Etizolam is combined with Magnesium Sulfate.
EtomidateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Etomidate.
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Magnesium Sulfate.
EtoperidoneThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Etoperidone.
EtorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Etorphine.
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Magnesium Sulfate.
EzogabineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.
EzogabineThe risk or severity of adverse effects can be increased when Ezogabine is combined with Magnesium Sulfate.
FelbamateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Felbamate.
FelbamateThe risk or severity of adverse effects can be increased when Felbamate is combined with Magnesium Sulfate.
FelodipineThe risk or severity of adverse effects can be increased when Felodipine is combined with Magnesium Sulfate.
FencamfamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fencamfamine.
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Magnesium Sulfate.
FendilineThe risk or severity of adverse effects can be increased when Fendiline is combined with Magnesium Sulfate.
FenfluramineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Fenfluramine.
FentanylMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fentanyl.
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Magnesium Sulfate.
FexofenadineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fexofenadine.
FexofenadineThe risk or severity of adverse effects can be increased when Fexofenadine is combined with Magnesium Sulfate.
FlibanserinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.
FlibanserinThe risk or severity of adverse effects can be increased when Flibanserin is combined with Magnesium Sulfate.
FluconazoleThe serum concentration of Magnesium Sulfate can be increased when it is combined with Fluconazole.
FlucytosineThe risk or severity of adverse effects can be increased when Flucytosine is combined with Magnesium Sulfate.
FludiazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fludiazepam.
FludiazepamThe risk or severity of adverse effects can be increased when Fludiazepam is combined with Magnesium Sulfate.
FlunarizineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
FlunarizineThe risk or severity of adverse effects can be increased when Flunarizine is combined with Magnesium Sulfate.
FlunitrazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Magnesium Sulfate.
FluoxetineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Fluoxetine.
FlupentixolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Magnesium Sulfate.
FluphenazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Magnesium Sulfate.
FlurazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Flurazepam.
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Magnesium Sulfate.
FluspirileneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fluspirilene.
FluspirileneThe risk or severity of adverse effects can be increased when Fluspirilene is combined with Magnesium Sulfate.
Fluticasone PropionateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fluticasone Propionate.
Fluticasone PropionateThe risk or severity of adverse effects can be increased when Fluticasone Propionate is combined with Magnesium Sulfate.
FluvoxamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
FluvoxamineThe risk or severity of adverse effects can be increased when Fluvoxamine is combined with Magnesium Sulfate.
FosphenytoinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.
FosphenytoinThe risk or severity of adverse effects can be increased when Fosphenytoin is combined with Magnesium Sulfate.
FospropofolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
FospropofolThe risk or severity of adverse effects can be increased when Fospropofol is combined with Magnesium Sulfate.
GabapentinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Magnesium Sulfate.
gabapentin enacarbilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of gabapentin enacarbil.
gabapentin enacarbilThe risk or severity of adverse effects can be increased when gabapentin enacarbil is combined with Magnesium Sulfate.
Gamma Hydroxybutyric AcidMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Gamma Hydroxybutyric Acid.
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Magnesium Sulfate.
GlutethimideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Magnesium Sulfate.
GlyphosateThe risk or severity of adverse effects can be increased when Glyphosate is combined with Magnesium Sulfate.
GriseofulvinThe risk or severity of adverse effects can be increased when Griseofulvin is combined with Magnesium Sulfate.
GuanfacineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.
GuanfacineThe risk or severity of adverse effects can be increased when Guanfacine is combined with Magnesium Sulfate.
HalazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Halazepam.
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Magnesium Sulfate.
HaloperidolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Magnesium Sulfate.
HaloproginThe risk or severity of adverse effects can be increased when Haloprogin is combined with Magnesium Sulfate.
HalothaneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Halothane.
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Magnesium Sulfate.
HeroinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Heroin.
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Magnesium Sulfate.
HexetidineThe risk or severity of adverse effects can be increased when Hexetidine is combined with Magnesium Sulfate.
HexobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.
HexobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Hexobarbital.
HydrocodoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HydrocodoneThe risk or severity of adverse effects can be increased when Hydrocodone is combined with Magnesium Sulfate.
HydromorphoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Magnesium Sulfate.
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Magnesium Sulfate.
IbandronateThe serum concentration of Ibandronate can be decreased when it is combined with Magnesium Sulfate.
IloperidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
IloperidoneThe risk or severity of adverse effects can be increased when Iloperidone is combined with Magnesium Sulfate.
ImipramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
ImipramineThe risk or severity of adverse effects can be increased when Imipramine is combined with Magnesium Sulfate.
IndalpineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Indalpine.
IndoraminIndoramin may increase the hypotensive activities of Magnesium Sulfate.
IsoconazoleThe risk or severity of adverse effects can be increased when Isoconazole is combined with Magnesium Sulfate.
IsofluraneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Magnesium Sulfate.
IsradipineThe risk or severity of adverse effects can be increased when Isradipine is combined with Magnesium Sulfate.
ItraconazoleThe risk or severity of adverse effects can be increased when Itraconazole is combined with Magnesium Sulfate.
KetamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Magnesium Sulfate.
KetazolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.
KetazolamThe risk or severity of adverse effects can be increased when Ketazolam is combined with Magnesium Sulfate.
KetobemidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ketobemidone.
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Magnesium Sulfate.
KetoconazoleThe risk or severity of adverse effects can be increased when Ketoconazole is combined with Magnesium Sulfate.
LabetalolLabetalol may increase the hypotensive activities of Magnesium Sulfate.
LacidipineThe risk or severity of adverse effects can be increased when Lacidipine is combined with Magnesium Sulfate.
LamotrigineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.
LamotrigineThe risk or severity of adverse effects can be increased when Lamotrigine is combined with Magnesium Sulfate.
LercanidipineThe risk or severity of adverse effects can be increased when Lercanidipine is combined with Magnesium Sulfate.
LevetiracetamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.
LevetiracetamThe risk or severity of adverse effects can be increased when Levetiracetam is combined with Magnesium Sulfate.
LevobupivacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.
LevobupivacaineThe risk or severity of adverse effects can be increased when Levobupivacaine is combined with Magnesium Sulfate.
LevocabastineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
LevocabastineThe risk or severity of adverse effects can be increased when Levocabastine is combined with Magnesium Sulfate.
LevocetirizineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.
LevocetirizineThe risk or severity of adverse effects can be increased when Levocetirizine is combined with Magnesium Sulfate.
LevodopaMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levodopa.
LevodopaThe risk or severity of adverse effects can be increased when Levodopa is combined with Magnesium Sulfate.
Levomethadyl AcetateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levomethadyl Acetate.
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Magnesium Sulfate.
LevomilnacipranThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Levomilnacipran.
LevorphanolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Magnesium Sulfate.
LevothyroxineThe serum concentration of Levothyroxine can be decreased when it is combined with Magnesium Sulfate.
LidocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.
LidocaineThe risk or severity of adverse effects can be increased when Lidocaine is combined with Magnesium Sulfate.
Lipoic AcidMagnesium Sulfate can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
LithiumMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lithium.
LithiumThe risk or severity of adverse effects can be increased when Lithium is combined with Magnesium Sulfate.
LofentanilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lofentanil.
LofentanilThe risk or severity of adverse effects can be increased when Lofentanil is combined with Magnesium Sulfate.
LoratadineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Loratadine.
LoratadineThe risk or severity of adverse effects can be increased when Loratadine is combined with Magnesium Sulfate.
LorazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Magnesium Sulfate.
LoxapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Magnesium Sulfate.
Lu AA21004Magnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lu AA21004.
Lu AA21004The risk or severity of adverse effects can be increased when Lu AA21004 is combined with Magnesium Sulfate.
LurasidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Magnesium Sulfate.
Magnesium hydroxideThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium hydroxide.
Magnesium oxideThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium oxide.
Magnesium salicylateThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium salicylate.
ManidipineThe risk or severity of adverse effects can be increased when Manidipine is combined with Magnesium Sulfate.
MaprotilineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.
MaprotilineThe risk or severity of adverse effects can be increased when Maprotiline is combined with Magnesium Sulfate.
MeclizineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Meclizine.
MeclizineThe risk or severity of adverse effects can be increased when Meclizine is combined with Magnesium Sulfate.
MedetomidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Medetomidine.
MedetomidineThe risk or severity of adverse effects can be increased when Medetomidine is combined with Magnesium Sulfate.
MefloquineThe therapeutic efficacy of Magnesium Sulfate can be decreased when used in combination with Mefloquine.
MelatoninMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Melatonin.
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Magnesium Sulfate.
MelperoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Melperone.
MelperoneThe risk or severity of adverse effects can be increased when Melperone is combined with Magnesium Sulfate.
MepivacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.
MepivacaineThe risk or severity of adverse effects can be increased when Mepivacaine is combined with Magnesium Sulfate.
MeprobamateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Magnesium Sulfate.
MesoridazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Magnesium Sulfate.
MetaxaloneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
MetaxaloneThe risk or severity of adverse effects can be increased when Metaxalone is combined with Magnesium Sulfate.
MethadoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methadone.
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Magnesium Sulfate.
Methadyl AcetateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methadyl Acetate.
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Magnesium Sulfate.
MethapyrileneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.
MethapyrileneThe risk or severity of adverse effects can be increased when Methapyrilene is combined with Magnesium Sulfate.
MethaqualoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.
MethaqualoneThe risk or severity of adverse effects can be increased when Methaqualone is combined with Magnesium Sulfate.
MethocarbamolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.
MethocarbamolThe risk or severity of adverse effects can be increased when Methocarbamol is combined with Magnesium Sulfate.
MethohexitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
MethohexitalThe metabolism of Magnesium Sulfate can be increased when combined with Methohexital.
MethotrimeprazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
MethotrimeprazineThe risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Magnesium Sulfate.
MethoxyfluraneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Magnesium Sulfate.
MethsuximideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.
MethsuximideThe risk or severity of adverse effects can be increased when Methsuximide is combined with Magnesium Sulfate.
MethylphenobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.
MethylphenobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Methylphenobarbital.
MetyrosineMagnesium Sulfate may increase the sedative activities of Metyrosine.
MevastatinThe risk or severity of adverse effects can be increased when Mevastatin is combined with Magnesium Sulfate.
MianserinThe therapeutic efficacy of Magnesium Sulfate can be decreased when used in combination with Mianserin.
MibefradilThe risk or severity of adverse effects can be increased when Mibefradil is combined with Magnesium Sulfate.
MicafunginThe risk or severity of adverse effects can be increased when Micafungin is combined with Magnesium Sulfate.
MiconazoleThe risk or severity of adverse effects can be increased when Miconazole is combined with Magnesium Sulfate.
MidazolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Magnesium Sulfate.
MilnacipranThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Milnacipran.
MiltefosineThe risk or severity of adverse effects can be increased when Miltefosine is combined with Magnesium Sulfate.
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Magnesium Sulfate.
MirtazapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
MirtazapineThe risk or severity of adverse effects can be increased when Mirtazapine is combined with Magnesium Sulfate.
MivacuriumMagnesium Sulfate may increase the neuromuscular blocking activities of Mivacurium.
MolindoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Molindone.
MolindoneThe risk or severity of adverse effects can be increased when Molindone is combined with Magnesium Sulfate.
MonensinThe risk or severity of adverse effects can be increased when Monensin is combined with Magnesium Sulfate.
MorphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Morphine.
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Magnesium Sulfate.
Mycophenolic acidThe serum concentration of Mycophenolic acid can be decreased when it is combined with Magnesium Sulfate.
MyxothiazolThe risk or severity of adverse effects can be increased when Myxothiazol is combined with Magnesium Sulfate.
NabiloneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Nabilone.
NafcillinThe metabolism of Magnesium Sulfate can be increased when combined with Nafcillin.
NaftifineThe risk or severity of adverse effects can be increased when Naftifine is combined with Magnesium Sulfate.
NalbuphineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Magnesium Sulfate.
NatamycinThe risk or severity of adverse effects can be increased when Natamycin is combined with Magnesium Sulfate.
NicardipineThe risk or severity of adverse effects can be increased when Nicardipine is combined with Magnesium Sulfate.
NifedipineThe risk or severity of adverse effects can be increased when Nifedipine is combined with Magnesium Sulfate.
NiguldipineThe risk or severity of adverse effects can be increased when Niguldipine is combined with Magnesium Sulfate.
NiludipineThe risk or severity of adverse effects can be increased when Niludipine is combined with Magnesium Sulfate.
NilvadipineThe risk or severity of adverse effects can be increased when Nilvadipine is combined with Magnesium Sulfate.
NimesulideThe risk or severity of adverse effects can be increased when Nimesulide is combined with Magnesium Sulfate.
NimodipineThe risk or severity of adverse effects can be increased when Nimodipine is combined with Magnesium Sulfate.
NisoldipineThe risk or severity of adverse effects can be increased when Nisoldipine is combined with Magnesium Sulfate.
NitrazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Magnesium Sulfate.
NitrendipineThe risk or severity of adverse effects can be increased when Nitrendipine is combined with Magnesium Sulfate.
NitroprussideMagnesium Sulfate may increase the hypotensive activities of Nitroprusside.
Nitrous oxideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Magnesium Sulfate.
NitroxolineThe risk or severity of adverse effects can be increased when Nitroxoline is combined with Magnesium Sulfate.
NormethadoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Normethadone.
NormethadoneThe risk or severity of adverse effects can be increased when Normethadone is combined with Magnesium Sulfate.
NortriptylineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
NortriptylineThe risk or severity of adverse effects can be increased when Nortriptyline is combined with Magnesium Sulfate.
NystatinThe risk or severity of adverse effects can be increased when Nystatin is combined with Magnesium Sulfate.
OlanzapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Magnesium Sulfate.
OlopatadineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Olopatadine.
OlopatadineThe risk or severity of adverse effects can be increased when Olopatadine is combined with Magnesium Sulfate.
OndansetronMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Magnesium Sulfate.
OpiumMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Opium.
OpiumThe risk or severity of adverse effects can be increased when Opium is combined with Magnesium Sulfate.
OrlistatThe serum concentration of Magnesium Sulfate can be decreased when it is combined with Orlistat.
OrphenadrineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
OrphenadrineThe risk or severity of adverse effects can be increased when Orphenadrine is combined with Magnesium Sulfate.
OsanetantMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Osanetant.
OsanetantThe risk or severity of adverse effects can be increased when Osanetant is combined with Magnesium Sulfate.
OxazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Magnesium Sulfate.
OxiconazoleThe risk or severity of adverse effects can be increased when Oxiconazole is combined with Magnesium Sulfate.
OxprenololMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.
OxprenololThe risk or severity of adverse effects can be increased when Oxprenolol is combined with Magnesium Sulfate.
OxybuprocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
OxybuprocaineThe risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Magnesium Sulfate.
OxycodoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Magnesium Sulfate.
OxymorphoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Magnesium Sulfate.
pafuramidineThe risk or severity of adverse effects can be increased when pafuramidine is combined with Magnesium Sulfate.
PaliperidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Magnesium Sulfate.
PamidronateThe serum concentration of Pamidronate can be decreased when it is combined with Magnesium Sulfate.
ParaldehydeMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
ParaldehydeThe risk or severity of adverse effects can be increased when Paraldehyde is combined with Magnesium Sulfate.
ParoxetineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Paroxetine.
PentamidineThe risk or severity of adverse effects can be increased when Pentamidine is combined with Magnesium Sulfate.
PentazocineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pentazocine.
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Magnesium Sulfate.
PentobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.
PentobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Pentobarbital.
PerampanelMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Perampanel.
PerampanelThe risk or severity of adverse effects can be increased when Perampanel is combined with Magnesium Sulfate.
PerhexilineThe risk or severity of adverse effects can be increased when Perhexiline is combined with Magnesium Sulfate.
PerospironeMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Perospirone.
PerospironeThe risk or severity of adverse effects can be increased when Perospirone is combined with Magnesium Sulfate.
PerphenazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Magnesium Sulfate.
PethidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Magnesium Sulfate.
PhenobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.
PhenobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Phenobarbital.
PhenoxyethanolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Phenoxyethanol.
PhenoxyethanolThe risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Magnesium Sulfate.
PhenytoinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.
PhenytoinThe risk or severity of adverse effects can be increased when Phenytoin is combined with Magnesium Sulfate.
PimozideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pimozide.
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Magnesium Sulfate.
PinaveriumThe risk or severity of adverse effects can be increased when Pinaverium is combined with Magnesium Sulfate.
PipamperoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.
PipamperoneThe risk or severity of adverse effects can be increased when Pipamperone is combined with Magnesium Sulfate.
PipotiazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.
PipotiazineThe risk or severity of adverse effects can be increased when Pipotiazine is combined with Magnesium Sulfate.
PizotifenMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.
PizotifenThe risk or severity of adverse effects can be increased when Pizotifen is combined with Magnesium Sulfate.
PomalidomideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.
PomalidomideThe risk or severity of adverse effects can be increased when Pomalidomide is combined with Magnesium Sulfate.
PosaconazoleThe risk or severity of adverse effects can be increased when Posaconazole is combined with Magnesium Sulfate.
PramipexoleMagnesium Sulfate may increase the sedative activities of Pramipexole.
PramocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.
PramocaineThe risk or severity of adverse effects can be increased when Pramocaine is combined with Magnesium Sulfate.
PrazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Prazepam.
PrazepamThe risk or severity of adverse effects can be increased when Prazepam is combined with Magnesium Sulfate.
PrazosinPrazosin may increase the hypotensive activities of Magnesium Sulfate.
PregabalinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
PregabalinThe risk or severity of adverse effects can be increased when Pregabalin is combined with Magnesium Sulfate.
PrenylamineThe risk or severity of adverse effects can be increased when Prenylamine is combined with Magnesium Sulfate.
PrilocaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.
PrilocaineThe risk or severity of adverse effects can be increased when Prilocaine is combined with Magnesium Sulfate.
PrimidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Primidone.
PrimidoneThe metabolism of Magnesium Sulfate can be increased when combined with Primidone.
ProcaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Procaine.
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Magnesium Sulfate.
ProchlorperazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Prochlorperazine.
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Magnesium Sulfate.
PromazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Promazine.
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Magnesium Sulfate.
PromethazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Promethazine.
PromethazineThe risk or severity of adverse effects can be increased when Promethazine is combined with Magnesium Sulfate.
ProparacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Proparacaine.
ProparacaineThe risk or severity of adverse effects can be increased when Proparacaine is combined with Magnesium Sulfate.
PropofolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Propofol.
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Magnesium Sulfate.
PropoxycaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Propoxycaine.
PropoxycaineThe risk or severity of adverse effects can be increased when Propoxycaine is combined with Magnesium Sulfate.
ProtriptylineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
ProtriptylineThe risk or severity of adverse effects can be increased when Protriptyline is combined with Magnesium Sulfate.
PSD502Magnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of PSD502.
PSD502The risk or severity of adverse effects can be increased when PSD502 is combined with Magnesium Sulfate.
QuazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Quazepam.
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Magnesium Sulfate.
QuetiapineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Magnesium Sulfate.
RadicicolThe risk or severity of adverse effects can be increased when Radicicol is combined with Magnesium Sulfate.
RaltegravirThe serum concentration of Raltegravir can be decreased when it is combined with Magnesium Sulfate.
RamelteonMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
RamelteonThe risk or severity of adverse effects can be increased when Ramelteon is combined with Magnesium Sulfate.
RapacuroniumMagnesium Sulfate may increase the neuromuscular blocking activities of Rapacuronium.
RemifentanilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Magnesium Sulfate.
RemoxiprideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Magnesium Sulfate.
ReserpineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Reserpine.
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Magnesium Sulfate.
RisedronateThe risk or severity of adverse effects can be increased when Risedronate is combined with Magnesium Sulfate.
RisedronateThe serum concentration of Risedronate can be decreased when it is combined with Magnesium Sulfate.
RisperidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Risperidone.
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Magnesium Sulfate.
RomifidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Romifidine.
RomifidineThe risk or severity of adverse effects can be increased when Romifidine is combined with Magnesium Sulfate.
RopiniroleMagnesium Sulfate may increase the sedative activities of Ropinirole.
RopivacaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.
RopivacaineThe risk or severity of adverse effects can be increased when Ropivacaine is combined with Magnesium Sulfate.
RotigotineMagnesium Sulfate may increase the sedative activities of Rotigotine.
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Magnesium Sulfate.
S-EthylisothioureaMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of S-Ethylisothiourea.
S-EthylisothioureaThe risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Magnesium Sulfate.
Salicylhydroxamic AcidThe risk or severity of adverse effects can be increased when Salicylhydroxamic Acid is combined with Magnesium Sulfate.
Salicylic acidThe risk or severity of adverse effects can be increased when Salicylic acid is combined with Magnesium Sulfate.
ScopolamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.
ScopolamineThe risk or severity of adverse effects can be increased when Scopolamine is combined with Magnesium Sulfate.
SecobarbitalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.
SecobarbitalThe metabolism of Magnesium Sulfate can be increased when combined with Secobarbital.
SertaconazoleThe risk or severity of adverse effects can be increased when Sertaconazole is combined with Magnesium Sulfate.
SertindoleMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Sertindole.
SertindoleThe risk or severity of adverse effects can be increased when Sertindole is combined with Magnesium Sulfate.
SertralineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Sertraline.
SevofluraneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Magnesium Sulfate.
SilodosinSilodosin may increase the hypotensive activities of Magnesium Sulfate.
SinefunginThe risk or severity of adverse effects can be increased when Sinefungin is combined with Magnesium Sulfate.
SirolimusThe risk or severity of adverse effects can be increased when Sirolimus is combined with Magnesium Sulfate.
Sodium oxybateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Sodium oxybateThe risk or severity of adverse effects can be increased when Sodium oxybate is combined with Magnesium Sulfate.
StiripentolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.
StiripentolThe risk or severity of adverse effects can be increased when Stiripentol is combined with Magnesium Sulfate.
SufentanilMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Sufentanil.
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Magnesium Sulfate.
SulconazoleThe risk or severity of adverse effects can be increased when Sulconazole is combined with Magnesium Sulfate.
SulpirideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Sulpiride.
SulpirideThe risk or severity of adverse effects can be increased when Sulpiride is combined with Magnesium Sulfate.
SuvorexantMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
SuvorexantThe risk or severity of adverse effects can be increased when Suvorexant is combined with Magnesium Sulfate.
TamsulosinTamsulosin may increase the hypotensive activities of Magnesium Sulfate.
TapentadolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.
TapentadolThe risk or severity of adverse effects can be increased when Tapentadol is combined with Magnesium Sulfate.
TasimelteonMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.
TasimelteonThe risk or severity of adverse effects can be increased when Tasimelteon is combined with Magnesium Sulfate.
TavaboroleThe risk or severity of adverse effects can be increased when Tavaborole is combined with Magnesium Sulfate.
Technetium Tc-99m MedronateThe serum concentration of Technetium Tc-99m Medronate can be decreased when it is combined with Magnesium Sulfate.
TemazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Temazepam.
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Magnesium Sulfate.
TerazosinTerazosin may increase the hypotensive activities of Magnesium Sulfate.
TerbinafineThe risk or severity of adverse effects can be increased when Terbinafine is combined with Magnesium Sulfate.
TerconazoleThe risk or severity of adverse effects can be increased when Terconazole is combined with Magnesium Sulfate.
TetrabenazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tetrabenazine.
TetrabenazineThe risk or severity of adverse effects can be increased when Tetrabenazine is combined with Magnesium Sulfate.
TetracaineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.
TetracaineThe risk or severity of adverse effects can be increased when Tetracaine is combined with Magnesium Sulfate.
TetrodotoxinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tetrodotoxin.
TetrodotoxinThe risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Magnesium Sulfate.
ThalidomideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
ThalidomideThe risk or severity of adverse effects can be increased when Thalidomide is combined with Magnesium Sulfate.
ThiamylalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
ThiamylalThe metabolism of Magnesium Sulfate can be increased when combined with Thiamylal.
ThiopentalMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Thiopental.
ThiopentalThe metabolism of Magnesium Sulfate can be increased when combined with Thiopental.
ThioridazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Thioridazine.
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Magnesium Sulfate.
ThiothixeneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Magnesium Sulfate.
ThymolThe risk or severity of adverse effects can be increased when Thymol is combined with Magnesium Sulfate.
TiagabineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.
TiagabineThe risk or severity of adverse effects can be increased when Tiagabine is combined with Magnesium Sulfate.
TiletamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tiletamine.
TiletamineThe risk or severity of adverse effects can be increased when Tiletamine is combined with Magnesium Sulfate.
TiludronateThe serum concentration of Tiludronate can be decreased when it is combined with Magnesium Sulfate.
TioconazoleThe risk or severity of adverse effects can be increased when Tioconazole is combined with Magnesium Sulfate.
TizanidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tizanidine.
TizanidineThe risk or severity of adverse effects can be increased when Tizanidine is combined with Magnesium Sulfate.
TolcaponeMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.
TolcaponeThe risk or severity of adverse effects can be increased when Tolcapone is combined with Magnesium Sulfate.
Tolfenamic AcidThe risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Magnesium Sulfate.
TolnaftateThe risk or severity of adverse effects can be increased when Tolnaftate is combined with Magnesium Sulfate.
TopiramateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Topiramate.
TopiramateThe risk or severity of adverse effects can be increased when Topiramate is combined with Magnesium Sulfate.
TramadolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tramadol.
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Magnesium Sulfate.
TranilastThe risk or severity of adverse effects can be increased when Tranilast is combined with Magnesium Sulfate.
Trans-2-PhenylcyclopropylamineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Trans-2-Phenylcyclopropylamine.
Trans-2-PhenylcyclopropylamineThe risk or severity of adverse effects can be increased when Trans-2-Phenylcyclopropylamine is combined with Magnesium Sulfate.
TranylcypromineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Magnesium Sulfate.
TrazodoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Trazodone.
TrazodoneThe risk or severity of adverse effects can be increased when Trazodone is combined with Magnesium Sulfate.
TriazolamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Magnesium Sulfate.
TriethylenetetramineThe serum concentration of Magnesium Sulfate can be decreased when it is combined with Triethylenetetramine.
TrifluoperazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Magnesium Sulfate.
TriflupromazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Magnesium Sulfate.
TrimazosinTrimazosin may increase the hypotensive activities of Magnesium Sulfate.
TrimetrexateThe risk or severity of adverse effects can be increased when Trimetrexate is combined with Magnesium Sulfate.
TrimipramineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Trimipramine.
TrimipramineThe risk or severity of adverse effects can be increased when Trimipramine is combined with Magnesium Sulfate.
TriprolidineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Triprolidine.
TriprolidineThe risk or severity of adverse effects can be increased when Triprolidine is combined with Magnesium Sulfate.
Valproic AcidMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Valproic Acid.
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Magnesium Sulfate.
VerapamilThe risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium Sulfate.
VigabatrinMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.
VigabatrinThe risk or severity of adverse effects can be increased when Vigabatrin is combined with Magnesium Sulfate.
VilazodoneThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Vilazodone.
VoriconazoleThe risk or severity of adverse effects can be increased when Voriconazole is combined with Magnesium Sulfate.
VortioxetineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
VortioxetineThe risk or severity of adverse effects can be increased when Vortioxetine is combined with Magnesium Sulfate.
XylazineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Xylazine.
XylazineThe risk or severity of adverse effects can be increased when Xylazine is combined with Magnesium Sulfate.
XylometazolineThe risk or severity of adverse effects can be increased when Xylometazoline is combined with Magnesium Sulfate.
ZaleplonMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Magnesium Sulfate.
ZiconotideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.
ZiconotideThe risk or severity of adverse effects can be increased when Ziconotide is combined with Magnesium Sulfate.
ZimelidineThe risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Zimelidine.
ZiprasidoneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Ziprasidone.
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Magnesium Sulfate.
ZolazepamMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zolazepam.
ZolazepamThe risk or severity of adverse effects can be increased when Zolazepam is combined with Magnesium Sulfate.
Zoledronic acidThe serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium Sulfate.
ZolpidemMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
ZolpidemThe risk or severity of adverse effects can be increased when Zolpidem is combined with Magnesium Sulfate.
ZonisamideMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.
ZonisamideThe risk or severity of adverse effects can be increased when Zonisamide is combined with Magnesium Sulfate.
ZopicloneMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Magnesium Sulfate.
ZotepineMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
ZotepineThe risk or severity of adverse effects can be increased when Zotepine is combined with Magnesium Sulfate.
ZuclopenthixolMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Magnesium Sulfate.
Food InteractionsNot Available

Targets

Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
This protein is a subunit of the dihydropyridine (DHP) sensitive calcium channel. Plays a role in excitation-contraction coupling. The skeletal muscle DHP-sensitive Ca(2+) channel may function only as a multiple subunit complex.
Gene Name:
CACNG1
Uniprot ID:
Q06432
Molecular Weight:
25028.105 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Plays an important role in excitation-contraction coupling (By similarity).
Gene Name:
CACNA2D1
Uniprot ID:
P54289
Molecular Weight:
124566.93 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1C gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belon...
Gene Name:
CACNA1C
Uniprot ID:
Q13936
Molecular Weight:
248974.1 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.
Gene Name:
CACNB1
Uniprot ID:
Q02641
Molecular Weight:
65712.995 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.
Gene Name:
CACNB2
Uniprot ID:
Q08289
Molecular Weight:
73579.925 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Voltage-gated calcium channel activity
Specific Function:
Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1S gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belon...
Gene Name:
CACNA1S
Uniprot ID:
Q13698
Molecular Weight:
212348.1 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on September 25, 2016 02:16